remdesivir - Covid Index

Topics

Parent Topic

pharmaceuticals

Information Sources addressing Topic

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19
Case report study of the first five COVID-19 patients treated with remdesivir in France
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Information for Clinicians on Investigational Therapeutics for Patients with COVID-19
Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigation
My Life in the Thrill Kill Medical Cult
New COVID-19 Treatments Add-On Payment (NCTAP)
News release: FDA Approves First Treatment for COVID-19
Rush to Use Ventilators Killed Thousands of COVID Patients
Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19
What the Nurses Saw
WHO advises that ivermectin only be used to treat COVID-19 within clinical trials

Topic ID

1038

© 2023 - 2024 The Covid Index. All rights reserved.